Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/15/24
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 06/20/23
End: 02/28/24
Due: 02/28/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of Ropivacaine Combined With Different Concentrations of Methylene Blue Fascia Iliaca Block in Postoperative Analgesia, Cognition, and Hip Function Recovery in Patients Undergoing Hip Arthroplasty | NCT06520306 | Wang wanxia | user2@example.com | None | 2024-03-15 | 2024-08-31 | 2025-08-31 | - | - | 2025-07-14 |
| A Study of Ropivacaine Complex Methylene Blue Fascia Iliaca Compartment Block on Analgesia in Patients Undergoing Hip Arthroplasty | NCT06284941 | Wang wanxia | user2@example.com | None | 2023-06-20 | 2024-02-28 | 2025-02-28 | - | - | 2025-07-14 |